Welcome to The Natural Chemotherapeutics Research Institute (NCRI) Resource Center


REMARKS BY DR GRACE KYEYUNE AT THE LAUNCH OF THE UBV-01N

The Natural Chemotherapeutics Research Institute is one of the beneficiaries of an investment by The Presidential Scientific Initiative on Epidemics (PRESIDE), into research studies to evaluate therapeutics that have potential to contribute to the fight of the SARS-COV-2 (COVID-19) pandemic.

STANDARD PROTOCOL

A multi-centre,  randomized, double-blind,  clinical trial to evaluate the safety and efficacy of herbal medicine compared to the  standard of care for the treatment of hospitalized patients with mild to moderate cases of novel coronavirus disease (COVID-19).  

COVID-19 - Hope is here by NCRI

A CLINICAL EVALUATION OF EFFICACY, SAFETY IMMUNOGENICITY AND RELIABILITY OF UBV-01N- A NOVAL NATURAL PRODUCT- IN ADULT PATIENTS INFECTED WITH SARS-COV-2 (COVID-19), IN UGANDA